comparemela.com
Latest Breaking News On - Luca mastorino - Page 1 : comparemela.com
Study Compares Benefits of Treating Inverse Psoriasis with IL-17, IL-23 Inhibitors
This retrospective, systematic review highlighted the lack of studies specifically addressing the needs of patients with inverse psoriasis.
Italy
Luca-mastorino
University-of-turin-department
Dermatology-clinic-of-turin-university-hospital
Dermatology-clinic
Turin-university-hospital
Psoriasis-area
Severity-index
Ixekizumab Shown to be Safe, Effective for Up to 5 Years for Psoriasis
These data on ixekizumab in real-world settings shed light on drug survival information for both those with psoriasis and those with psoriatic arthritis.
Italy
Italian
Dermatol-venereol
Luca-mastorino
Dermatologic-clinic-of-the-university-turin
University-of-turin
Dermatologic-clinic
Medical-sciences
Dermatology-life-quality-index
Eur-acad-dermatol
Opin-biol
Ixekizumab
vimarsana © 2020. All Rights Reserved.